Who
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth
Company insider
Files Form 4 as: EVP&Pres, Merck Animal Heallth, Merck & Company; Pres. Fort Dodge Animal Health, Wyeth.
In numbers
- Trades disclosed
- 128
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $82.5M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 23 Jan 2008
- Last trade
- 12 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $1.5M11,099 at $131.61 | filing |
| 12 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $79K600 at $132.04 | filing |
| 12 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $1.5M11,099 at $131.61 | filing |
| 12 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $79K600 at $132.04 | filing |
| 11 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $973K7,410 at $131.33 | filing |
| 11 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $718K5,427 at $132.35 | filing |
| 11 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $973K7,410 at $131.33 | filing |
| 11 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $718K5,427 at $132.35 | filing |
| 10 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $2.7M20,784 at $130.43 | filing |
| 10 Aug 2026filed 12 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $2.7M20,784 at $130.43 | filing |
| 6 Aug 2026filed 10 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $105K805 at $131.02 | filing |
| 6 Aug 2026filed 10 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $644K4,945 at $130.23 | filing |
| 6 Aug 2026filed 10 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $39K300 at $131.02 | filing |
| 6 Aug 2026filed 10 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $105K805 at $131.02 | filing |
| 6 Aug 2026filed 10 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $644K4,945 at $130.23 | filing |
| 6 Aug 2026filed 10 Aug 2026 | MRK Merck & CompanyPharmaceuticals | SEC FORM 4 Sold | $39K300 at $131.02 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —11,931 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —34,924 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —11,931 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —34,924 at $0.00 | filing |
News
Moderna, Merck shares fall on eagerly anticipated cancer vaccine resultsMRK · biopharmadive.com · 22 Oct 2026Merck & Co., Inc. $MRK Stock Sold by Smith Chas P & Associates PA CpasMRK · dailypolitical.com · 22 Oct 2026Merck's KEYTRUDA Plus Padcev Wins EU Approval For Muscle-Invasive Bladder CancerMRK · rttnews.com · 21 Oct 2026
0 headlines in the last 90 days name Richard R. DeLuca; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.